Pulmonx Corporation Price to Free Cash Flow Ratio 2019-2024 | LUNG
Historical price to free cash flow ratio values for Pulmonx Corporation (LUNG) since 2019.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pulmonx Corporation Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-02-21 | 8.96 | 0.00 | |
| 2024-09-30 | 8.29 | $-0.90 | 0.00 |
| 2024-06-30 | 6.34 | $-0.94 | 0.00 |
| 2024-03-31 | 9.27 | $-0.99 | 0.00 |
| 2023-12-31 | 12.75 | $-1.01 | 0.00 |
| 2023-09-30 | 10.33 | $-1.05 | 0.00 |
| 2023-06-30 | 13.11 | $-1.11 | 0.00 |
| 2023-03-31 | 11.18 | $-1.17 | 0.00 |
| 2022-12-31 | 8.43 | $-1.25 | 0.00 |
| 2022-09-30 | 16.66 | $-1.32 | 0.00 |
| 2022-06-30 | 14.72 | $-1.29 | 0.00 |
| 2022-03-31 | 24.81 | $-1.39 | 0.00 |
| 2021-12-31 | 32.07 | $-1.25 | 0.00 |
| 2021-09-30 | 35.98 | $-4.01 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||